IGM Biosciences, Inc.
IGMSDelisted Aug 14, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001496323
IGM Biosciences, Inc. was delisted on Aug 14, 2025; its insiders filed their last Form 4 on Aug 18, 2025; 66 institutions reported holding it in 13F filings for Q2 2025, worth $17.9M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding IGM Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 87 | 93 | +6 |
| Shares | 17.6M | 18.2M | +608.8K (+3.5%) |
| Value | $517.3M | $487.4M | −$30.0M (−5.8%) |
New holders (27)
Institutions that held IGM Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
Sold out (21)
Institutions that held IGM Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Pictet Asset Management SA | 934,965 | $27.4M |
| Polar Capital Holdings Plc | 106,436 | $3.12M |
| Entrust Global Partners L L C | 66,172 | $1.94M |
| Rafferty Asset Management, LLC | 56,057 | $1.64M |
| Walleye Capital LLC | 35,127 | $1.03M |
| Norges Bank | 34,463 | $1.01M |
| Qube Research & Technologies Ltd | 32,202 | $944.0K |
| Russell Investments Group, Ltd. | 25,345 | $742.0K |
| Two Sigma Advisers, LP | 22,600 | $663.0K |
| Group One Trading, L.P. | 12,173 | $357.0K |
| Erste Asset Management GmbH | 6,500 | $188.9K |
| MetLife Investment Management | 3,333 | $97.8K |
| Metropolitan Life Insurance Co | 2,302 | $67.5K |
| Amundi | 2,332 | $50.0K |
| Point72 Hong Kong Ltd | 1,149 | $34.0K |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 671 | $20.0K |
| Captrust Financial Advisors | 250 | $7.00K |
| Parallel Advisors, LLC | 70 | $2.00K |
| Tarbox Family Office, Inc. | 22 | $1.00K |
| Dark Forest Capital Management LP | 7 | $0 |
| Covestor Ltd | 8 | $0 |